Nutrition and pharmacological treatment for prevention of prostate cancer

Harefuah

Volumn 145, Issue 1 SPEC. ISS., 2006, Pages 47-51

  Segev, Yakir ^a   Nativ, Ofer ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Chemoprevention; Finasteride; Lycopene; Nutrition; Prostate cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

HUMAN; MALE; NUTRITION; PROSTATE TUMOR; REVIEW; RISK FACTOR;

ANTICARCINOGENIC AGENTS; HUMANS; MALE; NUTRITION PHYSIOLOGY; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 33644854232     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Jemal A, Tiwari RC, Murray T & al, Cancer statistics, 2004. CA Cancer J Clin, 2004; 54: 8.
2. Feuer EJ, Merrill RM & Hankey BF, Cancer surveillance series: interpreting trends in prostate cancer - part II: cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst, 1999; 91: 1025-1032.
3. Jemal A, Tiwari RC, Murray T & al, Cancer statistics, 2004. CA Cancer J Clin, 2004; 54: 8-29.
4. Kelloff GJ, Boone CW, Crowell JA & al, Risk biomarkers and current strategies for cancer chemoprevention. J Cell Biochem Suppl, 1996; 25: 1.
5. Sakr WA, Haas GP, Cassin BF & al, The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol, 1993; 150 (2 Pt 1): 379-385.
6. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 2000 Incidence. Atlanta, Ga: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2003.
7. Moul JW, Sesterhenn IA, Connelly RR & al, Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA, 1995; 274: 1277.
8. Whittemore AS, Kolonel LN, Wu AH & al, Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst, 1995; 87: 652-661.
9. Locke FB & King H, Cancer mortality risk among Japanese in the United States. J Natl Cancer Inst, 1980; 65: 1149-1156.
10. Hsieh K & Albertsen PC, Populations at high risk for prostate cancer. Urol Clin North Am, 2003; 30: 669-676.
11. Smith RA, Cokkinides V & Eyre HJ; American Cancer Society. American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin, 2004; 54: 41-52.
12. Freedland SJ, Aronson WJ, Kane CJ & al, Impact of obesity on biochemical control following radical prostatectomy for clinically localized prostate cancer. J Clin Oncol, 2004; 22: 446-453.
13. Rittmaster RS, Finasteride. N Engl J Med, 1994; 330: 120.
14. Trump DL, Waldstreicher JA, Kolvenbag G & al, Androgen antagonists: potential role in prostate cancer prevention. Urology, 2001; 57: 64.
15. Thompson IM, Goodman PJ, Tangen CM & al, The influence of finasteride on the development of prostate cancer. N Engl J Med, 2003; 349: 215-224.
16. Scardino PT, The prevention of prostate cancer-the dilemma continues. N Engl J Med, 2003; 349: 297-299.
17. Pruthi RS, Derksen E & Gaston K, Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review. J Urol, 2003; 169: 2352.
18. Osborne M, Boyle P & Lipkin M, Cancer prevention. Lancet, 1997; 349 Suppl 2: SII27.
19. Dahl AR, Grossi IM, Houchens DP & al, Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study. Clin Cancer Res,2000; 6: 3015.
20. Slawin K, Kadmon D, Park SH & al, Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras + myc-induced carcinomas in the mouse prostate reconstitution model system. Cancer Res, 1993; 53: 4461.
21. Thaller C, Shalev M, Frolov A & al, Fenretinide therapy in prostate cancer: effects on tissue and serum retinoid concentration. J Clin Oncol, 2000; 18: 3804.
22. Pienta KJ, Esper PS, Zwas F & al, Phase II chemoprevention trial of oral fenretinide in patients at risk for adenocarcinoma of the prostate. Am J Clin Oncol, 1997; 20: 36.
23. Giovannucci E, Rimm EB, Liu Y & al, A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst, 2002; 94: 391-398.
24. Boileau TW, Liao Z, Kim S & al, Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J Natl Cancer Inst, 2003; 95: 1578-1586.
25. Gann PH & Khachik F, Tomatoes or lycopene versus prostate cancer: is evolution anti-reductionist? J Natl Cancer Inst, 2003; 95: 1563-1565.
26. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med, 1994; 330: 1029.
27. Heinonen OP, Albanes D, Virtamo J & al, Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst, 1998; 90: 440.
28. Virtamo J, Pietinen P, Huttunen JK & al, Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA, 2003; 290: 476.
29. Rodriguez C, Jacobs EJ, Mondul AM & al, Vitamin E supplements and risk of prostate cancer in US. men. Cancer Epidemiol Biomarkers Prev, 2004; 13: 378-382.
30. th Edition.
31. Yoshizawa K, Willett WC, Morris SJ & al, Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst, 1998; 90: 1219-1224.
32. Klein EA, Thompson IM, Lippman SM & al, SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design. Prostate Cancer Prostatic Dis, 2000; 3: 145-151.
33. Giovannucci E, Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control, 1998; 9: 567-582.
34. Giovannucci E, Rimm EB, Wolk A & al, Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res, 1998; 58: 442-447.
35. Strom SS, Yamamura Y, Duphorne CM & al, Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr Cancer, 1999; 33: 20.
36. Messina MJ, Persky V, Setchell KD & al, Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer, 1994; 21: 113.
37. Kolonel LN, Hankin JH, Whittemore AS & al, Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev, 2000; 9: 795.
38. Tseng M, Breslow RA, DeVellis RF & Ziegler RG, Dietary patterns and prostate cancer risk in the National Health and Nutrition Examination Survey Epidemiological Follow-up Study cohort. Cancer Epidemiol Biomarkers Prev, 2004; 13: 71-77.
39. Leitzmann MF, Stampfer MJ, Michaud DS & al, Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr, 2004; 80: 204-216.
40. Schuurman AG, van den Brandt PA, Dorant E & al, Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study. Cancer, 1999; 86: 1019-1027.